Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10).

Hitz F, Kraus M, Pabst T, Hess D, Besse L, Silzle T, Novak U, Seipel K, Rondeau S, Stüdeli S, Vilei SB, Samaras P, Mey U, Driessen C; Swiss Group for Clinical Cancer Research SAKK.

Blood Cancer J. 2019 Aug 27;9(9):70. doi: 10.1038/s41408-019-0228-2.

2.

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.

Zucca E, Rondeau S, Vanazzi A, Østenstad B, Mey UJM, Rauch D, Wahlin BE, Hitz F, Hernberg M, Johansson AS, de Nully Brown P, Hagberg H, Ferreri AJM, Lohri A, Novak U, Zander T, Bersvendsen H, Bargetzi M, Mingrone W, Krasniqi F, Dirnhofer S, Hayoz S, Hawle H, Vilei SB, Ghielmini M, Kimby E; Swiss Group for Clinical Cancer Research and the Nordic Lymphoma Group.

Blood. 2019 Jul 25;134(4):353-362. doi: 10.1182/blood-2018-10-879643. Epub 2019 May 17.

PMID:
31101627
3.

Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.

Samaras P, Bargetzi M, Betticher DC, Driessen C, Duchosal MA, Heim D, Ketterer N, Lerch E, Matthes T, Mey U, Pabst T, Schmidt A, Taverna C, Zander T, Renner C.

Swiss Med Wkly. 2019 Apr 3;149:w20031. doi: 10.4414/smw.2019.20031. eCollection 2019 Mar 25.

4.

Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study.

Mark M, Klingbiel D, Mey U, Winterhalder R, Rothermundt C, Gillessen S, von Moos R, Pollak M, Manetsch G, Strebel R, Cathomas R.

Clin Genitourin Cancer. 2019 Apr;17(2):e323-e328. doi: 10.1016/j.clgc.2018.12.009. Epub 2019 Jan 2.

PMID:
30686756
5.

Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab.

Langerak AW, Ritgen M, Goede V, Robrecht S, Bahlo J, Fischer K, Steurer M, Trněný M, Mulligan SP, Mey UJM, Trunzer K, Fingerle-Rowson G, Humphrey K, Stilgenbauer S, Böttcher S, Brüggemann M, Hallek M, Kneba M, van Dongen JJM.

Blood. 2019 Jan 31;133(5):494-497. doi: 10.1182/blood-2018-03-839688. Epub 2018 Nov 19. No abstract available.

6.

Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma.

Driessen C, Müller R, Novak U, Cantoni N, Betticher D, Mach N, Rüfer A, Mey U, Samaras P, Ribi K, Besse L, Besse A, Berset C, Rondeau S, Hawle H, Hitz F, Pabst T, Zander T.

Blood. 2018 Nov 8;132(19):2097-2100. doi: 10.1182/blood-2018-05-851170. Epub 2018 Sep 20. No abstract available.

7.

Diagnosis and treatment of follicular lymphoma: an update.

Bargetzi M, Baumann R, Cogliatti S, Dietrich PY, Duchosal M, Goede J, Hitz F, Konermann C, Lohri A, Mey U, Novak U, Papachristofilou A, Stenner F, Taverna C, Zander T, Renner C.

Swiss Med Wkly. 2018 Jul 24;148:w14635. doi: 10.4414/smw.2018.14635. eCollection 2018. Review.

8.

ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma.

Buske C, Hutchings M, Ladetto M, Goede V, Mey U, Soubeyran P, Spina M, Stauder R, Trnený M, Wedding U, Fields P; ESMO Lymphoma Consensus Conference Panel Members.

Ann Oncol. 2018 Mar 1;29(3):544-562. doi: 10.1093/annonc/mdx413.

9.

Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome.

Fischer A, Bastian S, Cogliatti S, Mey U, Saub J, Schanz U, Padberg B, Hohloch K.

Hematol Oncol. 2018 Feb;36(1):370-371. doi: 10.1002/hon.2464. Epub 2017 Jul 6. No abstract available.

PMID:
28681549
10.

Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma.

Ribi K, Rondeau S, Hitz F, Mey U, Enoiu M, Pabst T, Stathis A, Fischer N, Clough-Gorr KM.

Support Care Cancer. 2017 Sep;25(9):2833-2842. doi: 10.1007/s00520-017-3698-4. Epub 2017 Apr 13.

PMID:
28405846
11.

Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.

Borchmann P, Haverkamp H, Lohri A, Mey U, Kreissl S, Greil R, Markova J, Feuring-Buske M, Meissner J, Dührsen U, Ostermann H, Keller U, Maschmeyer G, Kuhnert G, Dietlein M, Kobe C, Eich H, Baues C, Stein H, Fuchs M, Diehl V, Engert A.

Lancet Oncol. 2017 Apr;18(4):454-463. doi: 10.1016/S1470-2045(17)30103-1. Epub 2017 Feb 22.

PMID:
28236583
12.

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.

Mey UJ, Brugger W, Schwarb H, Pederiva S, Schwarzer A, Dechow T, Jehner P, Rauh J, Taverna CJ, Schmid M, Schmidt-Hieber M, Doerfel S, Fischer N, Ruefer A, Ziske C, Knauf W, Cathomas R, von Moos R, Hitz F, Sauter R, Hiendlmeyer E, Cantoni N, Bargetzi M, Driessen C.

Br J Haematol. 2017 Mar;176(5):770-782. doi: 10.1111/bjh.14481. Epub 2016 Dec 16.

PMID:
27983764
13.

Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation.

Mey UJM, Renner C, von Moos R.

Hematol Oncol. 2017 Dec;35(4):890-893. doi: 10.1002/hon.2353. Epub 2016 Sep 19.

PMID:
27641727
14.

Salvage Chemotherapy with R-DHAP in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma.

Schirmbeck NG, Mey UJ, Olivieri A, Ko YD, Kaiser U, Flieger D, Witzens-Harig M, Schmidt-Wolf IG.

Cancer Invest. 2016 Sep 13;34(8):361-72. doi: 10.1080/07357907.2016.1212062. Epub 2016 Sep 16.

PMID:
27635469
15.

Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment option.

Zimmermann M, Oehler C, Mey U, Ghadjar P, Zwahlen DR.

Radiat Oncol. 2016 Aug 30;11(1):110. doi: 10.1186/s13014-016-0690-y. Review.

16.

Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08.

Hitz F, Zucca E, Pabst T, Fischer N, Cairoli A, Samaras P, Caspar CB, Mach N, Krasniqi F, Schmidt A, Rothermundt C, Enoiu M, Eckhardt K, Berardi Vilei S, Rondeau S, Mey U.

Br J Haematol. 2016 Jul;174(2):255-63. doi: 10.1111/bjh.14049. Epub 2016 Mar 28.

PMID:
27018242
17.

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08).

Driessen C, Kraus M, Joerger M, Rosing H, Bader J, Hitz F, Berset C, Xyrafas A, Hawle H, Berthod G, Overkleeft HS, Sessa C, Huitema A, Pabst T, von Moos R, Hess D, Mey UJ.

Haematologica. 2016 Mar;101(3):346-55. doi: 10.3324/haematol.2015.135780. Epub 2015 Dec 11.

18.

Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experience.

Volk V, Cathomas R, Mark M, von Moos R, Klingbiel D, Brossart P, Mey U.

Support Care Cancer. 2016 May;24(5):2119-2128. doi: 10.1007/s00520-015-3015-z. Epub 2015 Nov 9.

PMID:
26553033
19.

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).

Mamot C, Klingbiel D, Hitz F, Renner C, Pabst T, Driessen C, Mey U, Pless M, Bargetzi M, Krasniqi F, Gigli F, Hany T, Samarin A, Biaggi C, Rusterholz C, Dirnhofer S, Zucca E, Martinelli G.

J Clin Oncol. 2015 Aug 10;33(23):2523-9. doi: 10.1200/JCO.2014.58.9846. Epub 2015 Jul 6. Erratum in: J Clin Oncol. 2015 Sep 20;33(27):3074.

PMID:
26150440
20.

Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.

Samaras P, Bargetzi M, Betticher DC, Duchosal MA, Heim D, Hess U, Ketterer N, Lerch E, Matthes T, Mey U, Pabst T, Taverna C, Zander T, Renner C.

Swiss Med Wkly. 2015 Feb 21;145:w14100. doi: 10.4414/smw.2015.14100. eCollection 2015. Review.

21.

Improved survival of older patients with multiple myeloma in the era of novel agents.

Mey UJ, Leitner C, Driessen C, Cathomas R, Klingbiel D, Hitz F.

Hematol Oncol. 2016 Dec;34(4):217-223. doi: 10.1002/hon.2205. Epub 2015 Apr 21.

PMID:
25898820
22.

Efficacy of triplet combination chemotherapy with oxaliplatin, irinotecan and capecitabine (OCX) in metastatic colorectal cancer in relation to RAS/RAF mutation status: results of a retrospective analysis.

Brunner S, von Moos R, Mey U, Camenisch Gross U, Freyholdt T, Cathomas R.

Oncol Res Treat. 2014;37(11):646-52. doi: 10.1159/000368313. Epub 2014 Oct 17.

PMID:
25427581
23.

Hairy cell leukemia: short review, today's recommendations and outlook.

Maevis V, Mey U, Schmidt-Wolf G, Schmidt-Wolf IG.

Blood Cancer J. 2014 Feb 14;4:e184. doi: 10.1038/bcj.2014.3.

24.

Outcome of mantle cell lymphoma patients treated at a single institution over the past decade.

Hitz F, Diem S, Haile SR, Ess S, Cerny T, Mey U.

Hematol Oncol. 2014 Dec;32(4):192-6. doi: 10.1002/hon.2123. Epub 2013 Dec 11.

PMID:
24338732
25.

Diagnosis and treatment of mantle cell lymphoma.

Hitz F, Bargetzi M, Cogliatti S, Lohri A, Taverna C, Renner C, Mey U.

Swiss Med Wkly. 2013 Nov 13;143:w13868. doi: 10.4414/smw.2013.13868. eCollection 2013. Review.

26.

The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients.

Clough-Gorr KM, Noti L, Brauchli P, Cathomas R, Fried MR, Roberts G, Stuck AE, Hitz F, Mey U.

BMC Med Inform Decis Mak. 2013 Aug 23;13:93. doi: 10.1186/1472-6947-13-93.

27.

Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial.

Hitz F, Fischer N, Pabst T, Caspar C, Berthod G, Eckhardt K, Berardi Vilei S, Zucca E, Mey U; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.

Ann Hematol. 2013 Aug;92(8):1033-40. doi: 10.1007/s00277-013-1751-z. Epub 2013 Apr 17.

PMID:
23592273
28.

Sequential Hodgkin's and non-Hodgkin's lymphoma in non-immunocompromised patients.

Khristi J, Mey U, Kirfel J, Schmidt-Wolf IG, Gütgemann I.

Ann Hematol. 2013 Nov;92(11):1565-7. doi: 10.1007/s00277-013-1742-0. Epub 2013 Apr 5. Review. No abstract available.

PMID:
23558907
29.

[Persistent Eosinophilia--differential diagnosis and work-up].

Peduzzi M, Schwitter M, Cathomas R, von Moos R, Wieland T, Mey U.

Praxis (Bern 1994). 2012 Mar 28;101(7):483-7. doi: 10.1024/1661-8157/a000890. German.

PMID:
22454311
30.

Diagnosis and treatment of diffuse large B-cell lymphoma.

Mey U, Hitz F, Lohri A, Pederiva S, Taverna C, Tzankov A, Meier O, Yeow K, Renner C.

Swiss Med Wkly. 2012 Jan 30;142:w13511. doi: 10.4414/smw.2012.13511. eCollection 2012. Review.

31.

[Proteins in haematology].

Clarenbach RE, Mey U.

Ther Umsch. 2011 Nov;68(11):610-7. doi: 10.1024/0040-5930/a000221. Review. German.

PMID:
22045523
32.

Diagnosis and treatment of follicular lymphoma.

Hitz F, Ketterer N, Lohri A, Mey U, Pederiva S, Renner C, Taverna C, Hartmann A, Yeow K, Bodis S, Zucca E.

Swiss Med Wkly. 2011 Aug 4;141:w13247. doi: 10.4414/smw.2011.13247. eCollection 2011. Review.

33.

[Current treatment strategies for multiple myeloma].

Mey UJ.

Ther Umsch. 2010 Oct;67(10):527-35. doi: 10.1024/0040-5930/a000089. Review. German.

PMID:
20886459
34.

Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.

Simons S, Ringsdorf S, Braun M, Mey UJ, Schwindt PF, Ko YD, Schmidt-Wolf I, Kuhn W, Jaehde U.

Support Care Cancer. 2011 Jul;19(7):1009-18. doi: 10.1007/s00520-010-0927-5. Epub 2010 Jun 16.

35.

Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations.

Taverna C, Bargetzi M, Betticher D, Gmür J, Gregor M, Heim D, Hess U, Ketterer N, Lerch E, Matthes T, Mey U, Pabst T, Renner C.

Swiss Med Wkly. 2010 Sep 13;140:w13054. doi: 10.4414/smw.2010.13054. eCollection 2010. Review.

36.

Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?

Cathomas R, Köberle D, Ruhstaller T, Mayer G, Räss A, Mey U, von Moos R.

Support Care Cancer. 2010 Oct;18(10):1263-70. doi: 10.1007/s00520-009-0740-1. Epub 2009 Sep 12.

PMID:
19756772
37.

Long-term survival of a patient with small cell lung cancer after nine lines of chemotherapy and radiation.

Gressner O, Popp H, Mey U, Friedrichs N, Strehl J, Sauerbruch T, Schmidt-Wolf IG, Gorschlüter M.

Onkologie. 2008 Sep;31(8-9):469-72. doi: 10.1159/000142396. Epub 2008 Aug 15.

PMID:
18787355
38.

Endoscopy in patients with acute leukaemia after intensive chemotherapy.

Gorschlüter M, Schmitz V, Mey U, Hahn-Ast C, Schmidt-Wolf IG, Sauerbruch T.

Leuk Res. 2008 Oct;32(10):1510-7. doi: 10.1016/j.leukres.2008.03.016. Epub 2008 May 20.

PMID:
18495243
39.

Paradoxical exacerbation of psoriasis during therapy with fludarabine.

Jordan J, Mey U, Bieber T, Wilsmann-Theis D.

Eur J Dermatol. 2008 May-Jun;18(3):365-6. doi: 10.1684/ejd.2008.0429. Epub 2008 May 13. No abstract available.

PMID:
18474491
40.

Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia.

Burmeister T, Schwartz S, Taubald A, Jost E, Lipp T, Schneller F, Diedrich H, Thomssen H, Mey UJ, Eucker J, Rieder H, Gökbuget N, Hoelzer D, Thiel E.

Haematologica. 2007 Dec;92(12):1699-702.

41.

CD4+ T lymphocyte counts after autologous transplantation in multiple myeloma: a retrospective study.

Gorschlüter M, Glasmacher A, Sarazin S, Hackbarth F, Hoebert E, Orlopp K, Schmidt-Wolf IG, Mey U.

Leuk Lymphoma. 2007 Mar;48(3):506-12.

PMID:
17454590
42.

Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.

Herold M, Haas A, Srock S, Neser S, Al-Ali KH, Neubauer A, Dölken G, Naumann R, Knauf W, Freund M, Rohrberg R, Höffken K, Franke A, Ittel T, Kettner E, Haak U, Mey U, Klinkenstein C, Assmann M, von Grünhagen U; East German Study Group Hematology and Oncology Study.

J Clin Oncol. 2007 May 20;25(15):1986-92. Epub 2007 Apr 9.

PMID:
17420513
43.

Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma.

Mey UJ, Maier A, Schmidt-Wolf IG, Ziske C, Forstbauer H, Banat GA, Reber M, Strehl JW, Gorschlueter M.

Support Care Cancer. 2007 Jul;15(7):877-84.

PMID:
17235504
44.

High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma.

Mey UJ, Jha V, Strehl JW, Gorschlueter M, Rabe C, Hoebert E, Popp H, Schmidt-Wolf IG.

Ger Med Sci. 2007 Jun 19;5:Doc02.

45.

DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis.

Mey UJ, Olivieri A, Orlopp KS, Rabe C, Strehl JW, Gorschlueter M, Hensel M, Flieger D, Glasmacher AG, Schmidt-Wolf IG.

Leuk Lymphoma. 2006 Dec;47(12):2558-66.

PMID:
17169800
46.

Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.

Mey UJ, Orlopp KS, Flieger D, Strehl JW, Ho AD, Hensel M, Bopp C, Gorschlüter M, Wilhelm M, Birkmann J, Kaiser U, Neubauer A, Florschütz A, Rabe C, Hahn C, Glasmacher AG, Schmidt-Wolf IG.

Cancer Invest. 2006 Oct;24(6):593-600.

PMID:
16982464
47.

Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients.

Gorschlüter M, Mey U, Strehl J, Schmitz V, Rabe C, Pauls K, Ziske C, Schmidt-Wolf IG, Glasmacher A.

BMC Infect Dis. 2006 Feb 26;6:35.

48.

Cholecystitis in neutropenic patients: retrospective study and systematic review.

Gorschlüter M, Mey U, Strehl J, Schepke M, Lamberti C, Sauerbruch T, Glasmacher A.

Leuk Res. 2006 May;30(5):521-8. Epub 2006 Feb 14. Review.

PMID:
16483649
49.

Acute myeloid leukemia with near-triploid karyotype and extramedullary involvement of mediastinum.

Gorschlüter M, Mey U, Glasmacher A, Schwerdtfeger R, Schmidt-Wolf IG.

Bone Marrow Transplant. 2005 Dec;36(12):1107. No abstract available.

PMID:
16247438
50.

Patients with malignancy requiring urgent therapy: CASE 1. Central airway obstruction as first presentation of ovarian cancer.

Tasci S, Kovacs A, Leutner C, Zivanovic O, Lüderitz B, Büttner R, Mey U.

J Clin Oncol. 2005 Sep 20;23(27):6791-3. No abstract available.

PMID:
16170186

Supplemental Content

Support Center